Ritholtz Wealth Management Raises Stake in LifeVantage Co. (NASDAQ:LFVN)

Ritholtz Wealth Management lifted its position in shares of LifeVantage Co. (NASDAQ:LFVN - Free Report) by 65.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,348 shares of the company's stock after purchasing an additional 18,682 shares during the quarter. Ritholtz Wealth Management owned 0.38% of LifeVantage worth $830,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Renaissance Technologies LLC boosted its holdings in LifeVantage by 2.1% during the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company's stock worth $5,490,000 after buying an additional 17,300 shares in the last quarter. Capital Management Corp VA acquired a new stake in shares of LifeVantage during the 3rd quarter valued at about $5,073,000. HighTower Advisors LLC purchased a new position in shares of LifeVantage in the 3rd quarter valued at about $638,000. Finally, Barclays PLC raised its holdings in LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company's stock worth $507,000 after purchasing an additional 11,608 shares during the period. 35.32% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Lake Street Capital began coverage on LifeVantage in a report on Thursday, December 19th. They issued a "buy" rating and a $26.00 price objective on the stock. Craig Hallum assumed coverage on shares of LifeVantage in a research note on Tuesday, January 14th. They issued a "buy" rating and a $35.00 price target on the stock.

LifeVantage Stock Performance

Shares of LFVN traded up $0.01 during mid-day trading on Monday, hitting $25.31. 134,842 shares of the company were exchanged, compared to its average volume of 112,642. LifeVantage Co. has a 1-year low of $5.22 and a 1-year high of $27.38. The stock has a market cap of $317.01 million, a price-to-earnings ratio of 79.10 and a beta of 0.82. The company has a 50 day moving average of $16.74 and a 200-day moving average of $12.16.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The firm had revenue of $47.21 million for the quarter.

LifeVantage Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Monday, December 2nd were given a dividend of $0.04 per share. The ex-dividend date was Monday, December 2nd. This represents a $0.16 dividend on an annualized basis and a yield of 0.63%. LifeVantage's payout ratio is presently 50.00%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.